Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Ganesh Pawar Article rating: 3.8

The market opened in green on November 11, 2020, overall volumes in futures & options currently stand at 3,42,04,412 contracts with a turnover of Rs. 27,13,906.22 crore.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Ganesh Pawar Article rating: 3.0

The market opened in green on November 11, 2020, overall volumes in futures & options currently stand at 3,42,04,412 contracts with a turnover of Rs. 27,13,906.22 crore.

Glenmark Pharma gets US regulator nod for generic version of Prograf; stock opens positive
Glenmark Pharma gets US regulator nod for generic version of Prograf; stock opens positive

Glenmark Pharma gets US regulator nod for generic version of Prograf; stock opens positive

Anthony Fernandes Article rating: 3.7

Glenmark Pharma informed the bourses today before the market hours that it has received final approval from United States Food & Drug Administration (USFDA) for Tacrolimus capsules USP, 0.5 mg, 1 mg & 5 mg, the generic version of Prograf 1 capsules, 0.5 mg, 1 mg & 5 mg of Astellas Pharma.

Nifty to open with minor gains as excitement over vaccine fizzles globally
Nifty to open with minor gains as excitement over vaccine fizzles globally

Nifty to open with minor gains as excitement over vaccine fizzles globally

Ganesh V Article rating: 4.0

SGX Nifty is trading with minor gains of about 33 odd points or 0.28 per cent on Wednesday. The global markets, especially the European markets, closed higher with gains of more than 1 per cent each on Tuesday on the back of optimism over the vaccine development. 

Reclassification of multi-cap funds begins
Reclassification of multi-cap funds begins

Reclassification of multi-cap funds begins

Henil Shah Article rating: 2.6

SEBI had recently introduced Flexi-cap as an additional category in equity schemes. Fund houses have started to reclassify their multi-cap schemes. Read on to find out more.

RSS
First19321933193419351937193919401941Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR